.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Clinicians recognize photodynamic immunotherapy for tumors as a promising treatment strategy. However, the immunosuppressive tumor microenvironment (TME) often limits its efficacy. Specifically, M2-like tumor-associated macrophages (TAMs) create a protective barrier around malignant cells. To address this, researchers developed an acid-responsive, mannose-functionalized nanoplatform called FI@PMD. M2-like macrophages selectively internalize this platform via mannose-receptor-mediated recognition. Consequently, this approach enables precise targeting within the TME.
Once the nanoplatform encounters acidic conditions, it undergoes structural dissociation. This process releases a near-infrared photosensitizer (FBC) and the Toll-like receptor 7 (TLR7) agonist imiquimod (IMQ). These components work in tandem to stimulate the immune system. Furthermore, the targeted delivery minimizes off-target effects in healthy tissues.
Upon light irradiation, the released FBC generates reactive oxygen species (ROS). These molecules trigger the polarization of TAMs from the M2 phenotype to the pro-inflammatory M1 phenotype. This transition remodels the TME and promotes an active anti-tumor response. In vivo experiments demonstrated that FI@PMD increased CD8+ cytotoxic T cell infiltration to 2.85-fold of the control group. Simultaneously, the proportion of regulatory T cells decreased. Therefore, this TAM-targeted strategy provides a powerful way to enhance photodynamic immunotherapy for tumors.
The nanoplatform features mannose functionalization, allowing it to be selectively internalized by M2-like tumor-associated macrophages through mannose-receptor-mediated recognition.
Repolarizing macrophages from the M2 to the M1 phenotype helps remodel the immunosuppressive tumor microenvironment, leading to significantly increased infiltration of cancer-killing CD8+ T cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new nanoplatform (FI@PMD) enhances photodynamic immunotherapy by repolarizing M2 macrophages to M1, boosting CD8+ T-cell infiltration in malignant tumors....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
